CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases
Microbiology Spectrum · 17.08.2023 · 11 (4)
DOI: 10.1128/spectrum.01329-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 17.08.2023. Verfasst von Concha Ortiz-Cartagena und 16 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary and Translational Microbiology Group (MicroTM), Biomedical Research Institute of A Coruña (INIBIC), Microbiology Service, Universit…. Hauptthemen laut MEDLINE: Bacterial Proteins, Nucleic Acids. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEC | Instituto de Salud Carlos III.
Abstract (Originalsprache)
Carbapenems are one of the last-resort antibiotics for defense against multidrug-resistant pathogens. Multiple nucleic acid amplification methods, including multiplex PCR, multiplex loop-mediated isothermal amplification (LAMP) and multiplex RPAs, can achieve rapid, accurate, and simultaneous detection of several resistance genes to carbapenems in a single reaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Multidisciplinary and Translational Microbiology Group (MicroTM), Biomedical Research Institute of A Coruña (INIBIC), Microbiology Service, University Hospital of A Coruña (CHUAC), University of A Coruña (UDC), A Coruña…
- Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.
- Microbiology Service, University Hospital Marqués de Valdecilla - IDIVAL, Santander, Spain.
- Microbiology Service, University Hospital Central de Asturias. Translational Microbiology Group, ISPA, Oviedo, Spain.
- CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
- Reference and Research Laboratory for Antibiotic Resistance and Health Care Infections, National Centre for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain.
ORCID-Profile: Lucía Blasco, Javier Fernández, Marta Hernández-García, María Tomás
Förderung
- MEC | Instituto de Salud Carlos III
Zitieren
APA
Ortiz-Cartagena, C., Pablo-Marcos, D., Fernández-García, L., Blasco, L., Pacios, O., Bleriot, I., Siller, M., López, M., Fernández, J., Aracil, B., Fraile-Ribot, P. A., García-Fernández, S., Fernández-Cuenca, F., Hernández-García, M., Cantón, R., Calvo-Montes, J., & Tomás, M. (2023). CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases. Microbiology Spectrum, 11(4). https://doi.org/10.1128/spectrum.01329-23
Vancouver
Ortiz-Cartagena C, Pablo-Marcos D, Fernández-García L, Blasco L, Pacios O, Bleriot I, et al. CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases. Microbiology Spectrum. 2023;11(4). doi:10.1128/spectrum.01329-23
BibTeX
@article{OrtizCartagena2023,
author = {Ortiz-Cartagena, Concha and Pablo-Marcos, Daniel and Fernández-García, Laura and Blasco, Lucía and Pacios, Olga and Bleriot, Inés and Siller, María and López, María and Fernández, Javier and Aracil, Belén and Fraile-Ribot, Pablo Arturo and García-Fernández, Sergio and Fernández-Cuenca, Felipe and Hernández-García, Marta and Cantón, Rafael and Calvo-Montes, Jorge and Tomás, María},
title = {CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases},
journal = {Microbiology Spectrum},
year = {2023},
volume = {11},
number = {4},
doi = {10.1128/spectrum.01329-23}
}
EUVIMED